Australia: Rights holders rearmed with preliminary discovery powers by Full Federal Court

Last Updated: 23 December 2017
Article by Richard Hoad and Sarah Martine

The Full Court's decision should ensure that the preliminary discovery process remains a real weapon in the armoury of rights holders who suspect that their rights are being infringed.

How can a party assess if litigation is worth the cost before launching it? Preliminary discovery is a mechanism by which a prospective applicant, which considers that it might have a legal claim against another party, can obtain relevant documents prior to the commencement of substantive proceedings, in order to assess the merits of its potential claim. But what must the applicant show?

The Full Federal Court decision of Pfizer Ireland Pharmaceuticals v Samsung Bioepis AU Pty Ltd [2017] FCAFC 193 makes it clear that a prospective applicant seeking an order for preliminary discovery only needs to have a reasonable belief that it may have the right to obtain relief from a prospective respondent.

Pfizer is concerned about potential patent infringement

The applicants (Pfizer) manufacture ENBREL, which is a biological medicine that is used in the treatment of autoimmune diseases such as rheumatoid arthritis, juvenile rheumatoid arthritis and psoriatic arthritis. The active ingredient in ENBREL is etanercept.

In July 2016, Samsung Bioepis AU Pty Ltd (SBA) obtained registration on the Australian Register of Therapeutic Goods of two pharmaceutical products containing etanercept as their active ingredient under the name BRENZYS. Pfizer was concerned that the manufacture of BRENZYS might infringe one or more of Pfizer's process patents. However, it did not have sufficient information to decide whether to commence patent infringement proceedings.

Faced with this dilemma, Pfizer utilised the Federal Court's preliminary discovery procedure. Pfizer sought preliminary discovery of certain documents that SBA lodged with the Therapeutic Goods Administration regarding the processes used to manufacture BRENZYS. Pfizer believed that these documents would enable it to decide whether or not to commence proceedings against SBA for patent infringement.

Preliminary discovery in the Federal Court

The relevant preliminary discovery procedure in the Federal Court is governed by Rule 7.23 of the Federal Court Rules 2011 (Cth), which allows a prospective applicant to apply to the Court for an order for discovery by a prospective respondent if the prospective applicant:

  • has a reasonable belief that it has the right to obtain relief in the Court from a prospective respondent;
  • after making reasonable inquiries, does not have sufficient information to decide whether to start proceedings to obtain such relief; and
  • reasonably believes that the prospective respondent has, or is likely to have, in its control documents directly relevant to the right to obtain the relief, and that inspection of the documents would assist in making the decision.

How the Court assessed Pfizer's evidence to support its application for preliminary discovery

The key issue before the Federal Court was whether the expert evidence that Pfizer put forward in support of its application showed that Pfizer reasonably believed that SBA might be infringing its patents. Dr Ibarra (Pfizer's Director and Group Leader of Process Development, Manufacturing Science and Technology) provided expert evidence relating to the technical aspects of the patents and the process dependence of biological medicines.

At first instance, Justice Burley refused Pfizer's application. He was not satisfied that Pfizer had demonstrated that it had a reasonable belief, as opposed to a "mere suspicion", that it may have the right to obtain relief from SBA for patent infringement, saying that the mere fact that BRENZYS and ENBREL are biosimilar products does not mean that the manufacturing processes for the products are the same.

On appeal, the Full Court considered the proper approach to be taken in relation to preliminary discovery applications and, in particular, the "reasonable belief" requirement. Three separate judgments were delivered, however there was broad agreement on the principles and Pfizer's appeal was unanimously upheld. The Full Court held that the evidence presented by Pfizer was sufficient to establish that it had a reasonable belief that it may have a right to obtain relief from SBA for patent infringement. As such, SBA was ordered to provide the discovery sought by Pfizer.

Requirements for preliminary discovery

Chief Justice Allsop observed that the language used in Rule 7.23 should be given its ordinary meaning and its wording used as the framework of analysis for deciding preliminary discovery applications. Any judicial guidance should not be elevated above this statutory formulation,

Bearing this in mind, Justice Perram provided the following useful guidance in relation to the requirements for seeking preliminary discovery:

  • the prospective applicant must prove that it has a belief that it may (not does) have a right to relief;
  • the prospective applicant must demonstrate that the belief is reasonable, either by reference to material known to the person holding the belief, or by other material subsequently placed before the Court;
  • a person deposing to the belief need not give evidence of the belief a second time, to the extent that additional material is placed before the Court on the issue of the reasonableness of the belief;
  • the question of whether the belief is reasonable requires asking whether a person apprised of all of the relevant material could reasonably believe that they may have a right to obtain relief;
  • one may believe that a person may have a case on certain material without one's mind being in any way inclined to the notion that they do have such a case; and
  • in practice, in order to defeat a claim for preliminary discovery, it will be necessary either to show that the subjectively held belief does not exist or, if it does, that there is no reasonable basis for thinking that there may be (not is) such a case.

Chief Justice Allsop noted, with apparent disapproval, that the application at first instance involved two days of hearings, and the application for leave and the appeal took a further two days. As the Chief Justice observed, the level of fact finding that took place was well beyond what was required by the language used in Rule 7.23.

Why this decision on preliminary discovery is good news for rights holders

The purpose of preliminary discovery is to enable a party to ascertain, in a reasonably efficient and cost-effective manner, whether the costs of substantive litigation are justified. As Chief Justice Allsop emphasised in this case, applications for preliminary discovery are summary in nature, and are not "mini-trials".

That purpose would be defeated if the process of applying for preliminary discovery was too burdensome or the hurdles were set too high - and, in particular, if the Court applied too rigorous a standard in the assessment of whether the applicant has a reasonable belief that it has the right to obtain relief. By definition, the prospective applicant has imperfect knowledge about the prospective respondent's conduct. The forming of the requisite belief will necessarily entail an element of speculation. The key question, as the Full Court recognises, is whether the belief which is formed is a reasonable one.

The Full Court's decision should ensure that the preliminary discovery process remains a real weapon in the armoury of rights holders who suspect that their rights are being infringed. It should also put a brake on the tendency for applications of this kind to become unnecessarily drawn out and costly.

Clayton Utz communications are intended to provide commentary and general information. They should not be relied upon as legal advice. Formal legal advice should be sought in particular transactions or on matters of interest arising from this bulletin. Persons listed may not be admitted in all states and territories.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
Similar Articles
Relevancy Powered by MondaqAI
 
Some comments from our readers…
“The articles are extremely timely and highly applicable”
“I often find critical information not available elsewhere”
“As in-house counsel, Mondaq’s service is of great value”

Related Topics
 
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
 
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions